164 related articles for article (PubMed ID: 31812670)
1. The emerging roles of KPNA2 in cancer.
Han Y; Wang X
Life Sci; 2020 Jan; 241():117140. PubMed ID: 31812670
[TBL] [Abstract][Full Text] [Related]
2. The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer.
Christiansen A; Dyrskjøt L
Cancer Lett; 2013 Apr; 331(1):18-23. PubMed ID: 23268335
[TBL] [Abstract][Full Text] [Related]
3. Novel roles of karyopherin subunit alpha 2 in hepatocellular carcinoma.
Yang X; Wang H; Zhang L; Yao S; Dai J; Wen G; An J; Jin H; Du Q; Hu Y; Zheng L; Chen X; Yi Z; Tuo B
Biomed Pharmacother; 2023 Jul; 163():114792. PubMed ID: 37121148
[TBL] [Abstract][Full Text] [Related]
4. Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.
Noetzel E; Rose M; Bornemann J; Gajewski M; Knüchel R; Dahl E
Oncogene; 2012 Apr; 31(16):2101-14. PubMed ID: 21909132
[TBL] [Abstract][Full Text] [Related]
5. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
[TBL] [Abstract][Full Text] [Related]
6. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
[TBL] [Abstract][Full Text] [Related]
7. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
[TBL] [Abstract][Full Text] [Related]
8. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
[TBL] [Abstract][Full Text] [Related]
10. KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation.
Ikenberg K; Valtcheva N; Brandt S; Zhong Q; Wong CE; Noske A; Rechsteiner M; Rueschoff JH; Caduff R; Dellas A; Obermann E; Fink D; Fuchs T; Krek W; Moch H; Frew IJ; Wild PJ
J Pathol; 2014 Oct; 234(2):239-52. PubMed ID: 24930886
[TBL] [Abstract][Full Text] [Related]
11. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
Alshareeda AT; Negm OH; Green AR; Nolan CC; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2015 Jun; 112(12):1929-37. PubMed ID: 25989275
[TBL] [Abstract][Full Text] [Related]
12. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
Cui X; Wang H; Wu X; Huo K; Jing X
J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
[TBL] [Abstract][Full Text] [Related]
14. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
[TBL] [Abstract][Full Text] [Related]
16. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
17. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer.
Wang CI; Wang CL; Wu YC; Feng HP; Liu PJ; Chang YS; Yu JS; Yu CJ
J Proteome Res; 2015 Apr; 14(4):1739-51. PubMed ID: 25728791
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.
Zhou LN; Tan Y; Li P; Zeng P; Chen MB; Tian Y; Zhu YQ
Oncotarget; 2017 Jan; 8(1):303-314. PubMed ID: 27974678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
